Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 27, 2017 8:03:44 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 27, 2017 8:11:04 GMT -5
Part of article
Maxim Group analyst Jason Kolbert recalled and encounter with Urbanski in a November research report when he and other sell-side analysts toured MannKind’s manufacturing operations. “On the tour, we met many enthusiastic folks including the chief medical officer. We discussed doing a call with physician users with him. He was ‘interested and engaged.’ Minutes later, the CEO told us ‘ignore him, today is his last day.’ It was, at best, unusual, and for us as analysts, a bit of a red flag, suggesting to us that things at Mannkind were not as they seemed to be...”
What does the future hold for MannKind? If the company has the same DNA as founder Alfred E. Mann, it is resilient. He had made a fortune in the electro-optical components and aerospace industries before setting his sights on medical research. Mann served as CEO of MannKind (one of more than a dozen companies he founded) from 2003 to January 2015 and as chairman from 2001 until Feb. 17, 2016, when he stepped down. Mann died a week later at the age of 90.
|
|
|
|
Post by sportsrancho on Dec 27, 2017 8:19:03 GMT -5
That’s very interesting,can you post the whole article because I can’t get to it?
|
|
|
|
Post by liane on Dec 27, 2017 8:22:39 GMT -5
sportsrancho@p4l, If you c/p the title of the article into your Google search - you should come up with links that get around the paywall. Works for a lot of articles.
|
|
|
|
Post by uvula on Dec 27, 2017 8:41:32 GMT -5
Thanks for posting the article but I suspect doing so violates barron's rules and proboards' rules.
|
|
|
|
Post by liane on Dec 27, 2017 8:47:16 GMT -5
I'm taking down the article - people can follow my instructions above if they want to view it.
|
|
|
|
Post by brentie on Dec 27, 2017 9:29:38 GMT -5
|
|
|
|
Post by boca1girl on Dec 27, 2017 10:28:19 GMT -5
From the article...”Minutes later, the CEO told us ‘ignore him, today is his last day.’ It was, at best, unusual, and for us as analysts, a bit of a red flag, suggesting to us that things at Mannkind were not as they seemed to be...”
That quote sounds pretty harsh. Does anyone think Mike actually said that regarding Ray U?
|
|
|
|
Post by madog365 on Dec 27, 2017 10:34:54 GMT -5
From the article...”Minutes later, the CEO told us ‘ignore him, today is his last day.’ It was, at best, unusual, and for us as analysts, a bit of a red flag, suggesting to us that things at Mannkind were not as they seemed to be...” That quote sounds pretty harsh. Does anyone think Mike actually said that regarding Ray U? Does't bother me at all if he did or didn't. The Maxim note from November came off generally pretty salty due to the fact that H.C Wainwright was picked over them for the offering after both companies issued $7 PT's at the same exact time. |
|
|
|
Post by factspls88 on Dec 27, 2017 12:41:55 GMT -5
sportsrancho sportsrancho, If you c/p the title of the article into your Google search - you should come up with links that get around the paywall. Works for a lot of articles. It works for this article. Stopped working for me for the WSJ a while back though. |
|
|
|
Post by sportsrancho on Dec 27, 2017 12:57:34 GMT -5
From the article...”Minutes later, the CEO told us ‘ignore him, today is his last day.’ It was, at best, unusual, and for us as analysts, a bit of a red flag, suggesting to us that things at Mannkind were not as they seemed to be...” That quote sounds pretty harsh. Does anyone think Mike actually said that regarding Ray U? From a smart guy on StockTwits: @rooksleanne Good move Mike. I don’t think he liked Urbanski. You never cold call Drs with Analysts. |
|
|
|
Post by kc on Dec 27, 2017 13:13:03 GMT -5
I subscribe to Barrons.
MannKind CEO, Exec Bought Stock in December
|
|
/production/original_573352236.gif)
